Faes Farma, S.A. (LON:0K9H)

Market Cap	1.27B
Revenue (ttm)	498.51M
Net Income (ttm)	91.72M
Shares Out	n/a
EPS (ttm)	0.29
PE Ratio	13.85
Forward PE	16.33
Dividend	0.12 (2.63%)
Ex-Dividend Date	Jul 3, 2025

Volume	804
Average Volume	2,724
Open	4.805
Previous Close	4.814
Day's Range	4.680 - 4.804
52-Week Range	3.270 - 4.830
Beta	0.19
RSI	60.24
Earnings Date	Feb 26, 2026

About Faes Farma

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. The company also engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, sec...

• Industry: Pharmaceutical Preparations
• Founded: 1933
• Employees: 1,775
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0K9H

Financial Performance

In 2024, Faes Farma's revenue was 510.04 million, an increase of 7.81% compared to the previous year's 473.09 million. Earnings were 111.36 million, an increase of 21.17%.

Financial numbers in EUR